All Stories

  1. Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography
  2. Exploring Melanoma Awareness in the Australian Adult Population: A Cross‐Sectional Survey
  3. 3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk
  4. The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention
  5. Automating skin colour assessment using 3D total‐body photography: A proof‐of‐concept study
  6. An Overview of Data Analysis Approaches and Biases in Unveiling the Impact of COVID-19 on Melanoma Diagnosis
  7. A longitudinal dataset of tile and corresponding dermoscopic images with metadata for identifying skin cancers
  8. Practice Guidelines for Teledermatology in Australia: 2025 Update
  9. Three-Dimensional Total Body Photography Enables Automated Obesity-Related Comorbidity Screening in Dermatology
  10. Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey
  11. Privacy in Imaging for Dermatology Research
  12. What Are Patients’ Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review
  13. Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia
  14. Unpredictable interdependence of invasive and in situ melanoma
  15. Attitudes Towards the Use of Artificial Intelligence in Dermatology: A Survey of Australian Dermatologists
  16. The deep imaging phenotype for melanoma risk stratification
  17. Estimation of Body Mass Index from 3-Dimensional Total Body Photography
  18. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study
  19. Combining Automated Lesion Risk and Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study
  20. Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology
  21. The impact of surgical complications on obstetricians’ and gynecologists’ well-being and coping mechanisms as second victims
  22. Sun safe practice in the sport sector: industry forum report September 2025
  23. Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
  24. Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
  25. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses
  26. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study
  27. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review
  28. Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study
  29. Protocol for the process evaluation of the GOAL trial: investigating how comprehensive geriatric assessment (CGA) improves patient-centred goal attainment in older adults with chronic kidney disease in the outpatient setting
  30. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study (Preprint)
  31. A Narrative Review: Opportunities and Challenges in Artificial Intelligence Skin Image Analyses Using Total Body Photography
  32. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses (Preprint)
  33. Working together to improve type 2 diabetes care: a Participatory Design project to address identified needs of people with diabetes and their healthcare professionals
  34. Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults
  35. Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis
  36. Learnings from implementing a surgical training program
  37. Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol
  38. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study (Preprint)
  39. Melanoma screening workshop summary report
  40. Skin cancer awareness in the personal services industry
  41. Skin Cancer Prevention Queensland: Sunscreen Industry Forum Report
  42. Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial
  43. Position statement: balancing the harms and benefits of sun exposure
  44. Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample
  45. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial
  46. Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
  47. Sun Exposure Summit position statement
  48. Consumer views of melanoma early detection using 3D total‐body photography: cross‐sectional survey
  49. Skin Cancer Prevention Queensland: towards a future of reduced skin cancer burden for Queenslanders
  50. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  51. The dynamic nature of naevi in adulthood: prospective population-based study using three-dimensional total-body photography
  52. Informing a position statement on the use of artificial intelligence in dermatology in Australia
  53. Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging
  54. Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
  55. Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review
  56. Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
  57. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  58. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study (Preprint)
  59. A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care
  60. Experience from an outright ban of commercial sunbeds in the Australian context
  61. Digital Technology in Skin Cancer Prevention and Early Detection
  62. Digital Technology in Skin Cancer Prevention and Early Detection (Preprint)
  63. Reasons behind Low Cervical Screening Uptake among South Asian Immigrant Women: A Qualitative Exploration
  64. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study (Preprint)
  65. Factors influencing participants’ engagement with an interactive text-message intervention to improve sun protection behaviors: “SunText” randomized controlled trial
  66. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  67. The Additive Value of 3D Total Body Imaging for Sequential Monitoring of Skin Lesions: A Case Series
  68. Describing the Skin Surface Ecosystem Using 3D Total Body Photography
  69. Anatomic Distribution of Cherry Angiomas in the General Population
  70. Reproducible Naevus Counts Using 3D Total Body Photography and Convolutional Neural Networks
  71. The impact on health outcomes of implementing electronic health records to support the care of older people in residential aged care: A scoping review
  72. Review of educational tools for skin self‐examination: A qualitative analysis of laypeople’s preferences
  73. Weight and weight control behaviors during long‐term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long‐term follow‐up study
  74. High variability in anatomic patterns of cutaneous photodamage: a population‐based study
  75. Development of a Checklist Tool to Assess the Quality of Skin Lesion Images Acquired by Consumers Using Sequential Mobile Teledermoscopy
  76. Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study
  77. The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World
  78. Changes in cancer preventive behaviours, screening and diagnosis during COVID‐19
  79. Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?
  80. Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis
  81. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
  82. Fertility-sparing treatment in early endometrial cancer: current state and future strategies
  83. Virtual melanoma checks during a pandemic
  84. Practice guidelines for teledermatology in Australia
  85. Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit
  86. A review of literature supporting the development of practice guidelines for teledermatology in Australia
  87. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia
  88. Consumer skin cancer screening preferences
  89. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial
  90. Long‐term deaths from melanoma according to tumor thickness at diagnosis
  91. Tweets about sunburn
  92. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study
  93. Self‐reported naevus density may lead to misclassification of melanoma risk
  94. Using Mobile Health Technology and Social Media for the Prevention and Early Detection of Skin Cancer
  95. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  96. What Can Twitter Tell Us about Skin Cancer Communication and Prevention on Social Media?
  97. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review
  98. Unintended sunburn after applying sunscreen
  99. 3D Total Body Photography for early melanoma detection
  100. What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi‐disciplinary team
  101. Multidisciplinary cancer care in Australia
  102. UV detection stickers can assist people to reapply sunscreen
  103. Is there a role for digital technology in measuring the value of skin self‐examination?
  104. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review (Preprint)
  105. How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial
  106. Patient-Reported Experiences After Hysterectomy: A Cross-Sectional Study of the Views of Over 2300 Women
  107. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review
  108. Can clinical decision making be enhanced by artificial intelligence?
  109. Challenges and controversies in the conservative management of uterine and ovarian cancer
  110. How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?
  111. The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting
  112. Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer
  113. Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primary
  114. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial
  115. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review (Preprint)
  116. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma
  117. Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial
  118. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
  119. Fighting Melanoma with Smartphones: A Snapshot of Where We are a Decade after App Stores Opened Their Doors
  120. Using Advances in Skin Imaging Technology and Genomics for the Early Detection and Prevention of Melanoma
  121. Why a randomized melanoma screening trial may be a good idea
  122. ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
  123. Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use
  124. Are psychological interventions effective on anxiety in cancer patients? A systematic review and meta-analyses
  125. All-cause death in young women with endometrial cancer who receive progesterone therapy
  126. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers
  127. Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer
  128. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
  129. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial (Preprint)
  130. Clinical trials, culture and language: More than meets the eye?
  131. Effect of solar ultraviolet radiation exposure on serum 25(OH)D concentration: a pilot randomised controlled trial
  132. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers (Preprint)
  133. Psychological distress among Indigenous Australian cancer survivors
  134. Time and treatments: It is what you make of it that counts
  135. Do hand-addressed envelopes improve community response rates for a longitudinal study?
  136. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors
  137. The validity and reliability of remote diabetic foot ulcer assessment using mobile phone images
  138. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years
  139. Nutrition interventions in patients with gynecological cancers requiring surgery
  140. Anxiety, depression and quality of life in people with pancreatic cancer and their carers
  141. Efficacy of smartphone applications in high-risk pigmented lesions
  142. The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer
  143. Greater Precision in Melanoma Prevention
  144. Factors associated with quality of care for patients with pancreatic cancer in Australia
  145. Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer
  146. A Randomized Trial on the Effect of Exercise Mode on Breast Cancer–Related Lymphedema
  147. Consumer teledermoscopy for melanoma diagnosis
  148. Can skin cancer prevention be improved through mobile technology interventions? A systematic review
  149. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study
  150. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study
  151. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study
  152. Economics of teledermatology
  153. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study
  154. Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study
  155. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study
  156. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  157. Self-Reported Changes in Sun-Protection Behaviors at Different Latitudes in Australia
  158. Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema
  159. Health-related quality of life among Indigenous Australians diagnosed with cancer
  160. Estimating Skin Cancer Risk: Evaluating Mobile Computer-Adaptive Testing
  161. Using a Delphi process to determine optimal care for patients with pancreatic cancer
  162. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  163. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients
  164. Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study
  165. Beyond survivorship? A discursive analysis of how people with pancreatic cancer negotiate identity transitions in their health
  166. A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
  167. Review of the Evidence of Lymphedema Treatment Effect
  168. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
  169. Consumer preferences for teledermoscopy screening to detect melanoma early
  170. Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer
  171. Redefining Dermatologists’ Role in Skin Cancer Early Detection and Follow-up Care
  172. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: Results from the LACE trial
  173. Consumer Teledermoscopy
  174. Incidence, Risk Factors, and Estimates of a Woman’s Risk for Developing Secondary Lower Limb Lymphedema and Lymphedema-Specific Supportive Care Needs in Women Treated for Endometrial Cancer
  175. Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population
  176. User preferences for text message-delivered skin cancer prevention and early detection
  177. Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial
  178. Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?
  179. Systematic Review of Interventions to Improve the Provision of Information for Adults with Primary Brain Tumors and Their Caregivers
  180. Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema
  181. Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer
  182. Women’s Perceptions of Their Lifestyle and Quality of Life Several Years After a Diagnosis of Endometrial Cancer
  183. Evaluation of a skin self examination attitude scale using an item response theory model approach
  184. Prevalence, predictors, and correlates of supportive care needs among women 3–5 years after a diagnosis of endometrial cancer
  185. Changes in Outdoor Workersʼ Sun-Related Attitudes, Beliefs, and Behaviors
  186. Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial
  187. Primary Prevention of Skin Cancer
  188. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy
  189. Quality of life of women with lower limb swelling or lymphedema 3–5years following endometrial cancer
  190. Clinical Skin Examination Outcomes After a Video-Based Behavioral Intervention
  191. Uptake of Skin Self-examination and Clinical Examination Behavior by Outdoor Workers
  192. Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
  193. Teledermatology: Its Use in the Detection and Management of Actinic Keratosis
  194. Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review
  195. Serum HE4 as a prognostic marker in endometrial cancer — A population based study
  196. Skin cancer detection by one click — are we any closer?
  197. Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer
  198. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-A population-based data linkage study
  199. An Instrument to Measure Adherence to Weight Loss Programs: The Compliance Praxis Survey-Diet (COMPASS-Diet)
  200. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia
  201. Advances in Skin Cancer Early Detection and Diagnosis
  202. The HealthyTexts study: A randomized controlled trial to improve skin cancer prevention behaviors among young people
  203. Determinants of Uptake of Whole-Body Skin Self-Examination in Older Men
  204. Nomogram to Predict the Probability of Relapse in Patients Diagnosed With Borderline Ovarian Tumors
  205. Enhanced Skin Self-examination: A Novel Approach to Skin Cancer Monitoring and Follow-up
  206. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  207. Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial
  208. Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors
  209. Health professionals' perspectives on information provision for patients with brain tumours and their families
  210. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  211. Quality and Readability of Information Materials for People with Brain Tumours and Their Families
  212. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia
  213. Characteristics of men aged 50 years or older who do not take up skin self-examination following an educational intervention
  214. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  215. The Children and Sunscreen Study
  216. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
  217. Possible Genetic Predisposition to Lymphedema after Breast Cancer
  218. Development and piloting of a brain tumour-specific question prompt list
  219. Personalised electronic messages to improve sun protection in young adults
  220. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
  221. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study
  222. Lymphedema After Breast or Gynecological Cancer: Use and Effectiveness of Mainstream and Complementary Therapies
  223. Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-examination in Men 50 Years or Older
  224. Quality of life of women with lower-limb lymphedema following gynecological cancer
  225. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice
  226. Factors associated with recall of media reports about vitamin D and sun protection
  227. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma
  228. In Vitro Model of Vitamin D Synthesis by UV Radiation in an Australian Urban Environment
  229. Laparoscopy or laparotomy for early endometrial cancer? – Authors' reply
  230. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
  231. Patterns, correlates, and prognostic significance of quality of life following breast cancer
  232. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting
  233. Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study
  234. Knowledge about health benefits of vitamin D in Queensland Australia
  235. Seasonal Variation in Measured Solar Ultraviolet Radiation Exposure of Adults in Subtropical Australia
  236. The skin awareness study: Promoting thorough skin self-examination for skin cancer among men 50years or older
  237. Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study
  238. Gynecological cancer survivors and community support services: referral, awareness, utilization and satisfaction
  239. What determines the health‐related quality of life among regional and rural breast cancer survivors?
  240. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer
  241. Recruiting older adults to health research studies: A systematic review
  242. Lymphedema Following Breast Cancer
  243. Vitamin D and sun protection: The impact of mixed public health messages in Australia
  244. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia
  245. Factors Associated With the Number of Lesions Excised for Each Skin Cancer
  246. The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy–General (FACT‐G)
  247. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma
  248. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
  249. Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function
  250. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers
  251. Gynecological cancer survivors’ health behaviors and their associations with quality of life
  252. Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia
  253. Elderly patients with stage III or IV ovarian cancer: should they receive standard care?
  254. Quality of life among patients with a brain tumor and their carers
  255. Medical cost-offsets from psychosocial care in breast cancer
  256. Sun protection and low levels of vitamin D: are people concerned?
  257. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions
  258. Lymphedema after gynecological cancer treatment
  259. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme
  260. Malnutrition among gynaecological cancer patients
  261. Reply
  262. What motivates men age ≥ 50 years to participate in a screening program for melanoma?
  263. Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial
  264. Supportive care needs of people with brain tumours and their carers
  265. Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?
  266. Clinical outcomes from skin screening clinics within a community-based melanoma screening program
  267. Who attends skin cancer clinics within a randomized melanoma screening program?
  268. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: Motivation to donate, altruism and aggression
  269. Increase in skin cancer screening during a community-based randomized intervention trial
  270. The functional assessment of cancer-vulvar: Reliability and validity
  271. Acceptability and feasibility of a community-based screening programme for melanoma in Australia
  272. Comparability of Skin Screening Histories Obtained by Telephone Interviews and Mailed Questionnaires: A Randomized Crossover Study
  273. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT
  274. Primary prevention of skin cancer: a review of sun protection in Australia and internationally
  275. Vulvar cancer patients' quality of life: a qualitative assessment
  276. Attitudes and intentions in relation to skin checks for early signs of skin cancer
  277. Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)
  278. Validity of Self-reported Skin Screening Histories
  279. Impaired Quality of Life in Patients Commencing Radiotherapy for Cancer
  280. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival
  281. Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer
  282. Impact of Videotaped Information on Frequency and Confidence of Breast Self-Examination
  283. Measurement of Quality of Life in Head and Neck Cancer Patients Utilizing the Quality of Life Radiation Therapy Questionnaire
  284. Primary fallopian tube carcinoma: the Queensland experience
  285. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma
  286. Quality of life changes during conformal radiation therapy for prostate carcinoma